Astria Therapeutics - 53 Year Dividend History | ATXS
Historical dividend payout and yield for Astria Therapeutics (ATXS) since 1971. The current TTM dividend payout for Astria Therapeutics (ATXS) as of December 20, 2024 is $0.00. The current dividend yield for Astria Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.537B |
$0.000B |
|
Astria Therapeutics is a biopharmaceutical company which focuses on therapies to treat allergic and immunological diseases. The company's program include STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Astria Therapeutics, formerly known as Catabasis Pharmaceuticals Inc., is based in BOSTON.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
